menu
    • menu

    Company profile for Vyome Therapeutics

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vyome Therapeutics is an innovation-driven, clinical stage specialty pharmaceutical company, working to treat inflammatory diseases with locally-acting, next generation therapeutic solutions. Vyome's management team members are leaders in the drug development field, with deep expertise and a proven track record of successfully launching over 50 products in the life sciences and in building visionary companies. Vyome has ...
    Vyome Therapeutics is an innovation-driven, clinical stage specialty pharmaceutical company, working to treat inflammatory diseases with locally-acting, next generation therapeutic solutions. Vyome's management team members are leaders in the drug development field, with deep expertise and a proven track record of successfully launching over 50 products in the life sciences and in building visionary companies. Vyome has a robust pipeline of novel locally-acting drug candidates designed to improve current standards of care for multifactorial diseases of unmet need which are underpinned by inflammation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vyome TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100, Overlook Center, 2nd Floor, Princeton, New Jersey, 08540
    Telephone
    Telephone
    +1 9738328147
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vyometx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vyome-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/vyometx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vyome Show Compelling Ph 2 Data on VT-1953 for Treatment of MFW
    Vyome Show Compelling Ph 2 Data on VT-1953 for Treatment of MFW

    06 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260406418998/en/Vyome-to-Present-Compelling-Phase-2-Clinical-Data-on-VT-1953-for-Treatment-of-MFW-at-AACR-2026

    BUSINESSWIRE
    06 Apr 2026
    Share Share
    Vyome Publishes Positive Preclinical Results For Uveitis
    Vyome Publishes Positive Preclinical Results For Uveitis

    18 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260218057794/en/Vyome-Announces-the-Publication-of-Positive-Preclinical-Results-in-Uveitis-Addressing-a-%243B-Potential-Market-Opportunity

    BUSINESSWIRE
    18 Feb 2026
    Share Share
    Vyome Files for VT-1953 Orphan Drug Status
    Vyome Files for VT-1953 Orphan Drug Status

    11 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260211929295/en/Vyome-Files-for-VT-1953-Orphan-Drug-Status-Furthers-Strategic-Focus-On-VT-1953-Program-Over-the-Next-6-Months

    BUSINESSWIRE
    11 Feb 2026
    Share Share
    Vyome Secures Full Funding For VT-1953 Phase 3 Trial
    Vyome Secures Full Funding For VT-1953 Phase 3 Trial

    02 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260202307193/en/Vyome-Successfully-Capitalizes-All-VT-1953-Funding-Requirements-For-Initial-Phase-3-Results

    BUSINESSWIRE
    02 Feb 2026
    Share Share
    Independent Analyst Values Vyome's VT-1953 At $1B Post Phase 3
    Independent Analyst Values Vyome's VT-1953 At $1B Post Phase 3

    27 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260127579000/en/Independent-Analyst-Values-Vyomes-VT-1953-at-USD-1-Billion-Upon-Successful-Completion-of-Phase-3-Study

    BUSINESSWIRE
    27 Jan 2026
    Share Share
    Vyome Reports Positive Final Phase 2 Results for VT-1953
    Vyome Reports Positive Final Phase 2 Results for VT-1953

    08 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251208813165/en/Vyome-Reports-Positive-Final-Phase-2-Results-for-VT-1953-Plans-to-Advance-Into-Pivotal-Study-For-FDA-Approval

    BUSINESSWIRE
    08 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search